Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Topical Treatment of Primary Focal Hyperhidrosis, Part 2

Author(s):  Zur Eyal

Issue:  Mar/Apr 2019 - Volume 23, Number 2
View All Articles in Issue

Page(s):  94-104

Note:  Electronic version includes errata or revisions.

Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 1
Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 2
Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 3
Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 4
Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 5
Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 6
Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 7
Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 8
Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 9
Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 10
Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 11

Download in electronic PDF format for $75

Abstract:  This represents part 2 of a 2-part article on the topic of primary focal hyperhidrosis. Part 1, which was published in the International Journal of Pharmaceutical Compounding’s January/February 2019 issue, provided a comprehensive review of the active pharmaceutical ingredients aluminum salts and methenamine in the treatment of primary focal hyperhidrosis. Part 2 provides a comprehensive review of the active pharmaceutical ingredients glycopyrronium salts and oxybutynin chloride in the treatment of primary focal hyperhidrosis.

Related Keywords: primary focal hyperhidrosis, excess sweating, exocrine sweat glands, sympathetic nervous system, topical preparations, aluminum salts, methenamine, glycopyrronium salts, glycopyrrolate, oxybutynin chloride, formulations, anticholinergic agents, antihidrotic agents, muscanergic receptors, eccrine glands, dosage forms, face, axilla, hand, foot, feet, patient satisfaction

Related Categories: DERMATOLOGY, FORMULATIONS, ADVERSE DRUG EVENTS, DOSAGE FORMS/DRUG CARRIERS, NEUROLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Topical Treatment of Primary Focal Hyperhidrosis, Part 2
Zur Eyal
Mar/Apr 2019
Pg. 94-104

Topical Treatment of Primary Focal Hyperhidrosis, Part 1
Zur Eyal
Jan/Feb 2019
Pg. 23-31

Topical Therapy for Localized Hyperhidrosis
Glasnapp Andrew
Jan/Feb 2001
Pg. 28-29

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

Erratum: Zur E. Topical Treatment of Primary Focal Hyperhidrosis, Part 2. IJPC 2019; 23(2):94-104.
Jul/Aug 2019
Pg. 351

Sensitization Therapy for Warts
Kuntz Rachael
Jul/Aug 2003
Pg. 266-270

Primary Engineering Controls in Pharmaceutical Compounding, Part 2: Biosafety Cabinets
Mulder Kyle
Jan/Feb 2020
Pg. 7-12

Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory
, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Sep/Oct 2015
Pg. 357-365

Basics of Compounding: Basics of Compounding with Organic Salts
Allen Loyd V Jr
Jul/Aug 2010
Pg. 322-326

Basics of Compounding: Basics of Compounding with Inorganic Salts
Allen Loyd V Jr
Mar/Apr 2011
Pg. 146-153

Hank's Balanced Salt Solution (Stock Solution)
Allen Loyd V Jr
Mar/Apr 2011
Pg. 160

Aluminum Chloride 6.25% in Anhydrous Alcohol
Allen Loyd V Jr
Jan/Feb 2022
Pg. 52

Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products
Wagner James T
Jul/Aug 2005
Pg. 284-290

Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures
Nahata Milap C
Mar/Apr 2016
Pg. 164-166

Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators
Mulder Kyle
Nov/Dec 2019
Pg. 447-452

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3
Zur Eyal
Sep/Oct 2019
Pg. 366-375

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2
Zur Eyal
Jul/Aug 2019
Pg. 288-293

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1
Zur Eyal
May/Jun 2019
Pg. 200-207

Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Zur Eyal
Nov/Dec 2011
Pg. 458-463

Return to Top